Merck KGaA (OTCMKTS:MKKGY) Sees Large Volume Increase – Here’s What Happened

Shares of Merck KGaA (OTCMKTS:MKKGY) saw unusually-strong trading volume on Monday . Approximately 590,027 shares traded hands during trading, an increase of 613% from the previous session’s volume of 82,742 shares.The stock last traded at $25.0750 and had previously closed at $25.76.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft downgraded shares of Merck KGaA from a “buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Merck KGaA Stock Down 2.6%

The company has a current ratio of 1.49, a quick ratio of 0.97 and a debt-to-equity ratio of 0.36. The stock has a 50-day simple moving average of $29.59 and a 200-day simple moving average of $27.64. The company has a market cap of $16.21 billion, a price-to-earnings ratio of 11.15, a price-to-earnings-growth ratio of 2.25 and a beta of 0.96.

Merck KGaA (OTCMKTS:MKKGY) last issued its quarterly earnings results on Thursday, March 5th. The company reported $0.28 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.19). Merck KGaA had a net margin of 12.31% and a return on equity of 9.02%. The business had revenue of $6.11 billion for the quarter, compared to analyst estimates of $6.20 billion. As a group, analysts predict that Merck KGaA will post 1.87 EPS for the current year.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.